TY - JOUR
T1 - Phorbol Ester-Induced Reversible Inactivation of Cytotoxic T Cell Function
T2 - Correlation with Down-Regulation of Protein Kinase C Activity
AU - Ohmori, Hitoshi
AU - Shimada, Toshitaka
AU - Hikida, Masaki
AU - Takai, Toshiyuki
PY - 1994
Y1 - 1994
N2 - When an H-2d-specific cytotoxic T lymphocytes (CTL) clone, FC1, was incubated in the presence of 10-7 M phorbol myristate acetate (PMA) for 10-12 hr, the cytolytic activity of the CTL against H-2d target cells was abrogated, but was reversibly restored to the normal level after subsequent incubation of the cells in PMA-free medium for more than 10 hr. These effects of PMA have been reported (Russell, J.H.: J. Immunol. 133, 907- 912 (1984)), but the mode of its action has not been fully investigated. Here, we analyzed the biochemical basis of the PMA-induced loss of cytolytic activity. Cycloheximide completely blocked the restoration of the PMA-suppressed cytolytic activity, suggesting that protein synthesis was required in this process. PMA-treatment did not affect the levels of CD3 and CD8 molecules expressed on the CTL, nor was the level of a CTL-specific serine esterase, BLT esterase, affected by this treatment. However, the target cell-induced release of BLT esterase from the CTL was suppressed if the cells were pretreated with PMA. PMA-treatment of the CTL led to the down-regulation of protein kinase C (PKC) activity by about 50%. On the other hand, staurosporin, an inhibitor of PKC, completely blocked the target cell lysis when added at 10-M. These results suggest that the down-regulation of at least some isoform(s) of PKC is responsible for the PMA-induced loss of the cytotolytic activity of CTL.
AB - When an H-2d-specific cytotoxic T lymphocytes (CTL) clone, FC1, was incubated in the presence of 10-7 M phorbol myristate acetate (PMA) for 10-12 hr, the cytolytic activity of the CTL against H-2d target cells was abrogated, but was reversibly restored to the normal level after subsequent incubation of the cells in PMA-free medium for more than 10 hr. These effects of PMA have been reported (Russell, J.H.: J. Immunol. 133, 907- 912 (1984)), but the mode of its action has not been fully investigated. Here, we analyzed the biochemical basis of the PMA-induced loss of cytolytic activity. Cycloheximide completely blocked the restoration of the PMA-suppressed cytolytic activity, suggesting that protein synthesis was required in this process. PMA-treatment did not affect the levels of CD3 and CD8 molecules expressed on the CTL, nor was the level of a CTL-specific serine esterase, BLT esterase, affected by this treatment. However, the target cell-induced release of BLT esterase from the CTL was suppressed if the cells were pretreated with PMA. PMA-treatment of the CTL led to the down-regulation of protein kinase C (PKC) activity by about 50%. On the other hand, staurosporin, an inhibitor of PKC, completely blocked the target cell lysis when added at 10-M. These results suggest that the down-regulation of at least some isoform(s) of PKC is responsible for the PMA-induced loss of the cytotolytic activity of CTL.
KW - Cytotoxic T cell
KW - Phorbol ester
KW - Protein kinase C
KW - Serine esterase
KW - Target cell lysis
UR - http://www.scopus.com/inward/record.url?scp=0028606842&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028606842&partnerID=8YFLogxK
U2 - 10.1254/jjp.66.427
DO - 10.1254/jjp.66.427
M3 - Article
C2 - 7723218
AN - SCOPUS:0028606842
SN - 0021-5198
VL - 66
SP - 427
EP - 432
JO - Japanese Journal of Pharmacology
JF - Japanese Journal of Pharmacology
IS - 4
ER -